Health In Tech Inc (NASDAQ:HIT) shares, rose in value, with the stock price down by -4.59% to the previous day’s close as strong demand from buyers drove the stock to $7.06.
Actively observing the price movement in the recent trading, the stock is buoying the session at $7.40. The PE ratio was 210.12 over 12-month period. Referring to stock’s 52-week performance, its high was $7.58, and the low was $4.82. On the whole, HIT has fluctuated by 37.89% over the past month.
With the market capitalization of Health In Tech Inc currently standing at about $381.73 million, investors are eagerly awaiting this quarter’s results, scheduled for in April.
The stock’s technical analysis shows that the price of HIT currently trading nearly 8.91% and 20.14% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 61.39, while the 7-day volatility ratio is showing 7.93% which for the 30-day chart, stands at 7.22%. Furthermore, Health In Tech Inc (HIT)’s average true range (ATR) is 0.49.
Data on historical trading for Health In Tech Inc (NASDAQ:HIT) indicates that the trading volumes over the past 3 months, they’ve averaged 1.31 million. According to company’s latest data on outstanding shares, there are 42.37 million shares outstanding.
Nearly 85.58% of Health In Tech Inc’s shares belong to company insiders and institutional investors own 0.01% of the company’s shares. The stock has risen by 31.84% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the HIT stock heading into the next quarter.
